| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 07/31/2008 | WO2008089565A1 Cancerous disease modifying antibodies |
| 07/31/2008 | WO2008047243A3 Pharmaceutical composition for suppression of apoptosis and method for delivering the same |
| 07/31/2008 | WO2007059298A3 Chimeric immunoreceptor useful in treating human cancers |
| 07/31/2008 | US20080182788 Compositions and Methods for Increasing Bone Mineralization |
| 07/31/2008 | US20080182294 Recombinant clostridial neurotoxins (botulinum) having functional binding, translocation, and therapeutic domains; also an amino acid sequence susceptible to specific cleavage by proteases in vitro following expression as a single chain; inserts; therapeutic agents, transporter molecules; drug delivery |
| 07/31/2008 | US20080182266 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/31/2008 | US20080181918 Immunogens; vaccines; fusion proteins |
| 07/31/2008 | US20080181884 administering a synergistic mixture comprising an antibody, Anidulafungin (LY303366) and amphotericin B; for drug resistanct infections; induce immunology response; diagnosis of a patient with a Coccidioidomycosis infection |
| 07/31/2008 | CA2676481A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/31/2008 | CA2675293A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2675292A1 Cancerous disease modifying antibodies |
| 07/31/2008 | CA2674897A1 Cancerous disease modifying antibodies |
| 07/30/2008 | EP1950302A2 Streptococcus antigens |
| 07/30/2008 | EP1950299A1 Mammalian receptor proteins; related reagents and methods |
| 07/30/2008 | EP1950226A2 Receptors for human interleukin-12 |
| 07/30/2008 | EP1950221A2 Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis |
| 07/30/2008 | EP1948802A1 Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response |
| 07/30/2008 | EP1948692A2 Rankl antibody-pth/pthrp chimeric molecules |
| 07/30/2008 | EP1651665B1 Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain |
| 07/30/2008 | EP1025124B1 Low-toxicity human interferon-alpha analogues |
| 07/30/2008 | CN101230104A Recombinant protein containing a c-terminal fragment of plasmodium msp-1 |
| 07/30/2008 | CN101230100A Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 07/30/2008 | CN100406472C Fusion and solubility expression of cobratoxin and acidolysis release and purification of recombinant toxin |
| 07/29/2008 | US7405276 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 07/29/2008 | US7405273 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 07/29/2008 | US7405269 Identification and isolation of novel DNA and recombinant production of novel polypeptides |
| 07/29/2008 | US7405053 Modified amino acid sequence compared to the wild-type; interaction determined by detecting change in cellular signal; fusion proteins and vectors |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/24/2008 | WO2007121184A3 Compounds and methods for diagnosis and treatment of leishmaniasis |
| 07/24/2008 | WO2007109697A3 The use of protein s fusion for protein solubilization |
| 07/24/2008 | WO2004067717A3 Modified trafficking patterns for arrestin and g-protein-coupled receptors via arrestin-ubiquitin chimera |
| 07/24/2008 | US20080178309 Fluorescent Indicators of Hydrogen Peroxide and Methods for Using Same |
| 07/24/2008 | US20080176805 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/24/2008 | US20080176803 or Nicastrin complex with the novel protein Sambiasin; drugs screening, drug targets, diagnosis or prognosis of Alzheimer's disease; neurodegenerative diseases and developmental disorders caused by defects in the Notch pathway; fusion protein |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176280 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 07/24/2008 | US20080176279 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 07/24/2008 | US20080175896 high affinity to a fibroblast growth factor-inducible 14 (Fn14) cell surface receptor; induce cell death; drug target at diseased cell of cancer, atherosclerosis, stroke, lupus, nephritis, multiple sclerosis, rheumatoid arthritis, degenerative or inflammation; reduce side effect |
| 07/24/2008 | US20080175853 Virus-like particles for the induction of autoantibodies |
| 07/24/2008 | CA2674552A1 Vaccine |
| 07/23/2008 | EP1947187A1 Hybrid expression of neisserial proteins |
| 07/23/2008 | EP1947181A1 Mutant paramyxovirus and method for production thereof |
| 07/23/2008 | EP1946770A1 Uses of DC-sign and DC-signr for inhibiting hepatitis C virus infection |
| 07/23/2008 | EP1945674A2 Therapeutic anti-her2 antibody fusion polypeptides |
| 07/23/2008 | EP1945663A1 Insulin-like growth factor ii (igf-ii) binding factors |
| 07/23/2008 | EP1328287B1 Compositions and methods for wt1 specific immunotherapy |
| 07/23/2008 | EP1248841B1 Genes differentially expressed in breast cancer |
| 07/23/2008 | EP1165797B1 Particles for gene therapy |
| 07/23/2008 | EP1032688B1 Single-chain bifunctional glycoprotein hormones |
| 07/23/2008 | CN101225397A Construction of fusion gene pronucleus vector for IL-24 and EGF and uses thereof |
| 07/23/2008 | CN101225114A Method for breeding pest-resistant plants as well as special proteins and genes therefor |
| 07/23/2008 | CN101225113A Thymosin alpha1-thymopentin fusion peptide and preparation method thereof |
| 07/23/2008 | CN101225112A Soluble fusion protein |
| 07/23/2008 | CN100404673C Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 07/23/2008 | CN100404551C Disulfide cross-linked glycoprotein hormone analogs, their preparation and use |
| 07/22/2008 | US7402655 Nucleotide sequences coding polypeptide for use in the treatment of canccer, inflamation and infectious disorders |
| 07/22/2008 | US7402436 Lentiviral vectors for site-specific gene insertion |
| 07/22/2008 | US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines |
| 07/22/2008 | CA2141427C Expression of recombinant fusion proteins in attenuated bacteria |
| 07/17/2008 | WO2008083493A1 Stabilization of cyclic peptide structures |
| 07/17/2008 | WO2008024767A3 Method and composition for treating a fibrotic disorder |
| 07/17/2008 | WO2007097812A3 Therapeutic anti-her2 antibody fusion polypeptides |
| 07/17/2008 | US20080171855 Polyvalent protein complex |
| 07/17/2008 | US20080171362 Polynucleotides Encoding Proteins with Clot-Specific Streptokinase Activity |
| 07/17/2008 | DE4393381B4 PTH-Verbindungen mit PTH-ähnlicher Aktivität, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Zusammensetzungen und deren Verwendungen PTH compounds having PTH-like activity, to processes for their preparation, pharmaceutical compositions containing them and their uses |
| 07/17/2008 | CA2675024A1 Stabilization of cyclic peptide structures |
| 07/16/2008 | EP1944319A1 T1R Taste Receptors and Genes Encoding Same |
| 07/16/2008 | EP1944317A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/16/2008 | EP1943269A2 Neisseria meningitidis antigens |
| 07/16/2008 | EP1476541B1 Cytokine (zcytor17 ligand) |
| 07/16/2008 | CN101219215A Compounds and methods for treatment and diagnosis of chlamydial infection |
| 07/15/2008 | US7399849 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 07/15/2008 | US7399838 Polypetide for use in the treatment of viral disease and cancer |
| 07/15/2008 | US7399832 heterologous polypeptide selected from the group consisting of an Fc polypeptide, a peptide linker, and/or a leucine zipper polypeptide; use in the diagnosis and treatment of nervous system and cell adhesion disorders; to identify human chromosome 7; nonglycosylated form |
| 07/15/2008 | US7399828 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/15/2008 | US7399601 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners |
| 07/15/2008 | US7399473 Virus coat protein/receptor chimeras and method of use |
| 07/15/2008 | US7399468 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 07/15/2008 | CA2205557C Monofunctional and/or polyfunctional polylysine conjugates |
| 07/10/2008 | WO2008081812A1 Anti-tumor peptide and use thereof |
| 07/10/2008 | WO2008081466A1 Tumor suppressor activating polypeptides and uses thereof |
| 07/10/2008 | WO2008080218A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/10/2008 | US20080167240 Albumin Fusion Proteins |
| 07/10/2008 | US20080167239 Albumin Fusion Proteins |
| 07/10/2008 | US20080167227 biodrug laminin protein as angiogenesis inhibitors, antitumor agents; Inducing apoptosis in tissues; binding antibodies |
| 07/10/2008 | US20080166768 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof |
| 07/10/2008 | US20080166743 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 07/10/2008 | US20080166342 Major histocompatibility complex specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, inflammatory, autoimmune, liver and kidney disorders |
| 07/10/2008 | US20080166341 Cripto blocking antibodies and uses thereof |
| 07/10/2008 | CA2674304A1 Methods and compositions for enhanced protein expression and purification |
| 07/10/2008 | CA2673668A1 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 07/09/2008 | EP1942190A2 Immoglobulin fusion proteins having modified effector functions and uses thereof |
| 07/09/2008 | EP1942187A1 Cytokine protein family |
| 07/09/2008 | EP1942114A2 Mammalian cytokines; related reagents and methods |
| 07/09/2008 | EP1941043A1 Method for the recombinant expression of a polypeptide |
| 07/09/2008 | EP1940882A1 A peptide-immunoglobulin-conjugate |
| 07/09/2008 | EP1404362B1 Signal-1/signal-2 bifunctional peptide inhibitors |
| 07/09/2008 | EP0832189B2 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 07/09/2008 | CN101214372A Construction method of protein vaccine for in vivo inducing autoantibody aiming at TNF-alpha molecule |